Max Schlaak Patrick Schmidt Christopher Bangard Peter Kurschat Cornelia Mauch Hinrich Abken
10.18632/oncotarget.437
Oncotarget
2012 Jan;3(1):22-30.
CC BY
https://pubmed.ncbi.nlm.nih.gov/22289880/
Antibodies, Monoclonal, Murine-Derived / therapeutic use Melanoma / therapy Neoplastic Stem Cells / immunology Skin Neoplasms / therapy
Antibodies, Monoclonal, Murine-Derived / therapeutic use Melanoma / therapy Neoplastic Stem Cells / immunology Skin Neoplasms / therapy Case Reports Research Support, Non-U.S. Gov't Aged Antibodies / administration & dosage Antibodies / therapeutic use Antibodies, Monoclonal, Murine-Derived / administration & dosage Antineoplastic Combined Chemotherapy Protocols / therapeutic use Dacarbazine / administration & dosage Foot Humans Male Melanoma / pathology Molecular Targeted Therapy Neoplastic Stem Cells / drug effects Neoplastic Stem Cells / pathology Remission Induction Rituximab Skin Neoplasms / pathology Tumor Burden Antibodies Antibodies, Monoclonal, Murine-Derived Rituximab Dacarbazine
PMC3292889
22289880
Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells
2012